Shares of New Zealand’s a2 Milk Co. Ltd jumped more than 12 percent before trading in the stock was halted, after local media reported that the dairy company was close to winning an approval to sell baby formula in the United States.
A2 dismissed the report. The company had in May confirmed an application to the U.S. Food and Drug Administration (FDA) seeking permission to supply baby food to the country.
A2 Milk’s stock price shot up as much as 12.2 percent to NZ$5.60 to hit its highest level since April 5. Australia-listed shares of the firm jumped nearly 12 percent to A$5.08, before eventually being halted….